zacks
J&J Wins CHMP Nod for Expanded Use of Multiple Myeloma Drug Tecvayli
Johnson & Johnson JNJ announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval for the expanded use of Tecvayli (teclistamab) in multiple myeloma.The CHMP has now recommended approval of Tecvayli in combination with the Darz…